Physician profile
Michael Dell Mann
NPI 1588650949
$1,287.68
in general payments reported to CMS, 2019-2025
9 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.37 · 2021: $82.14 · 2022: $125 · 2023: $564 · 2024: $318 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.06 |
| Travel and Lodging | $477.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $539.94 | 2021-2023 | 1688, Spy-Phi System |
| Smith+Nephew, INC. | $421.97 | 2021-2025 | Grafix Pl, Collagenase Santyl, Stravix Pl |
| Ets Wound Care LLC | $151.12 | 2024 | Mirragen Advanced Wound Matrix |
| Gilead Sciences, INC. | $79.66 | 2019 | |
| Hydrofera LLC | $23.53 | 2022 | |
| Organogenesis INC. | $21.78 | 2025 | Apligraf |
| Reprise Biomedical, INC. | $19.55 | 2025 | Miro3d |
| Boston Scientific Corporation | $15.42 | 2023 | Lithovue |
| Cook Medical LLC | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.